Clinical trial
A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
NCT00001443 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 1995
- Completion date
- October 31, 2000
- Enrollment
- 63
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.